Xavier Carbonell-Estrany

Summary

Country: Spain

Publications

  1. ncbi [Guidelines for respiratory syncytial virus prophylaxis. An update]
    X Carbonell-Estrany
    Instituto Clínico de Ginecología, Obstetricia y Neonatología, Unidad integrada de Pediatria, Hospital Clinic, Barcelona, Spain
    An Esp Pediatr 56:334-6. 2002
  2. ncbi Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings
    Xavier Carbonell-Estrany
    Institut Clinic de Ginecologia Obstetricia i Neonatologia, Hospital Clinic, Barcelona, Spain
    Pediatr Infect Dis J 23:S193-201. 2004
  3. ncbi Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation
    John S Sampalis
    Department of Surgery and Medicine, McGill University and JSS Medical Research Inc, Montreal, Quebec, Canada
    Med Decis Making 28:471-80. 2008
  4. ncbi A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study
    Eric A F Simoes
    Department of Pediatrics, The University of Colorado School of Medicine and The Children s Hospital, Denver, USA
    Respir Res 9:78. 2008
  5. ncbi Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial
    Xavier Carbonell-Estrany
    Neonatology Service, Hospital Clinic, Agrupació Sanitèria Clínic, Hospital de Sant Joan de Deu, Barcelona, Spain
    Pediatrics 125:e35-51. 2010
  6. ncbi Health economics and RSV
    Xavier Carbonell-Estrany
    Hospital Clinic Maternitat, Institut Clinic de Ginecologia, Obstetricia Neonatologia, Barcelona, Spain
    Paediatr Respir Rev 10:12-3. 2009
  7. ncbi Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age
    X Carbonell-Estrany
    Hospital Clinic, Institut Clinic de Ginecologia Obstetricia i Neonatologia, Neonatology Service, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 27:891-9. 2008
  8. ncbi Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection
    X Carbonell-Estrany
    Service of Neonatology, Hospital Clinic, C Sabino Arana 1, E 08028 Barcelona, Spain
    Arch Dis Child Fetal Neonatal Ed 93:F85-9. 2008
  9. ncbi Erythropoietin and prematurity--where do we stand?
    Xavier Carbonell-Estrany
    Servicio de Neonatologia, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Hospital Clinic, Unidad integrada de Pediatria, IDIBAPS, Universidad de Barcelona, Barcelona, Spain
    J Perinat Med 33:277-86. 2005
  10. ncbi Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
    Xavier Carbonell-Estrany
    Servei de Neonatologia, Hospital Clinic, Institut Clinic de Ginecologia, Obstetrica i Neonatologia, Barcelona, Spain
    Respir Res 3:S1-2. 2002

Detail Information

Publications32

  1. ncbi [Guidelines for respiratory syncytial virus prophylaxis. An update]
    X Carbonell-Estrany
    Instituto Clínico de Ginecología, Obstetricia y Neonatología, Unidad integrada de Pediatria, Hospital Clinic, Barcelona, Spain
    An Esp Pediatr 56:334-6. 2002
    ..To date, there are no data that indicate the need to modify the guidelines for RSV prophylaxis in premature infants published in 2000...
  2. ncbi Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings
    Xavier Carbonell-Estrany
    Institut Clinic de Ginecologia Obstetricia i Neonatologia, Hospital Clinic, Barcelona, Spain
    Pediatr Infect Dis J 23:S193-201. 2004
    ..Prematurity leads to an increased need for, and duration of, hospital admission, intensive care, mechanical ventilation and supplemental oxygen, as well as increased mortality...
  3. ncbi Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation
    John S Sampalis
    Department of Surgery and Medicine, McGill University and JSS Medical Research Inc, Montreal, Quebec, Canada
    Med Decis Making 28:471-80. 2008
    ....
  4. ncbi A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study
    Eric A F Simoes
    Department of Pediatrics, The University of Colorado School of Medicine and The Children s Hospital, Denver, USA
    Respir Res 9:78. 2008
    ..The aim of this study, conducted in Europe, was to develop a validated risk factor based model to predict RSV-related hospitalisation in premature infants born 33-35 weeks' gestational age (GA)...
  5. ncbi Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial
    Xavier Carbonell-Estrany
    Neonatology Service, Hospital Clinic, Agrupació Sanitèria Clínic, Hospital de Sant Joan de Deu, Barcelona, Spain
    Pediatrics 125:e35-51. 2010
    ..We compared the efficacy and safety of motavizumab, an investigational monoclonal antibody with enhanced anti-RSV activity in preclinical studies, with palivizumab...
  6. ncbi Health economics and RSV
    Xavier Carbonell-Estrany
    Hospital Clinic Maternitat, Institut Clinic de Ginecologia, Obstetricia Neonatologia, Barcelona, Spain
    Paediatr Respir Rev 10:12-3. 2009
    ..Its use is efficient from the NHS perspective, since the cost of a QALY, even in the least favourable scenarios, is lower than the threshold of 30,000euro/QALY considered socially acceptable in Europe...
  7. ncbi Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age
    X Carbonell-Estrany
    Hospital Clinic, Institut Clinic de Ginecologia Obstetricia i Neonatologia, Neonatology Service, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 27:891-9. 2008
    ..Implementation of this model and prophylaxis of infants born between 33 and 35 weeks GA should be a national or regional decision, taken in perspective of other public health needs...
  8. ncbi Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection
    X Carbonell-Estrany
    Service of Neonatology, Hospital Clinic, C Sabino Arana 1, E 08028 Barcelona, Spain
    Arch Dis Child Fetal Neonatal Ed 93:F85-9. 2008
    ....
  9. ncbi Erythropoietin and prematurity--where do we stand?
    Xavier Carbonell-Estrany
    Servicio de Neonatologia, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Hospital Clinic, Unidad integrada de Pediatria, IDIBAPS, Universidad de Barcelona, Barcelona, Spain
    J Perinat Med 33:277-86. 2005
    ..It should be started at 3-7 days of life at doses of 250 U/kg subcutaneously, three times a week, for 4-6 weeks depending on gestational age with oral iron 2-12 mg/kg/day to keep ferritin levels greater than 100 ng/mL...
  10. ncbi Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
    Xavier Carbonell-Estrany
    Servei de Neonatologia, Hospital Clinic, Institut Clinic de Ginecologia, Obstetrica i Neonatologia, Barcelona, Spain
    Respir Res 3:S1-2. 2002
  11. ncbi Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
    Carmen Pedraz
    , Barcelona, Spain
    Pediatr Infect Dis J 22:823-7. 2003
    ..83 to 5.25). CONCLUSION: Data from this study support the effectiveness of palivizumab in significantly modifying RSV-related hospitalizations in high risk preterm infants, with and without CLD, during two respiratory seasons...
  12. ncbi Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain
    Jose Figueras-Aloy
    Hospital Clinic, Unitat Integrada Pediatría, Institut d Investigacions Biomediques August Pi i Sunyer, 0828 Barcelona, Spain
    Pediatr Infect Dis J 23:815-20. 2004
    ..The aim of this study was to identify those risk factors most likely to lead to the development of RSV-related respiratory Infection and subsequent hospital admission among premature infants born at 33-35 WGA (FLIP study)..
  13. ncbi FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks
    Jose Figueras-Aloy
    Neonatology Hospital Clínic, Institut de Ginecologia, Obstetricia i Neonatologia, Barcelona, Spain
    Pediatr Infect Dis J 27:788-93. 2008
    ....
  14. ncbi Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease
    Josep Figueras-Aloy
    Department of Obstetrics and Neonatology, Institut Clínic deGinecologia, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
    Pediatrics 125:139-44. 2010
    ....
  15. ncbi Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study
    Francesc Botet
    Neonatology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain
    J Perinat Med 38:269-73. 2010
    ..To assess the relationship between maternal clinical chorioamnionitis and neonatal outcome in preterm very-low birthweight (VLBW) infants...
  16. ncbi Validation of a model to predict hospitalization due to RSV of infants born at 33-35 weeks' gestation
    Xavier Carbonell-Estrany
    Neonatology Service, Hospital Clinic, Institut Clinic de Ginecologia Obstetricia i Neonatologia, Barcelona, Spain
    J Perinat Med 38:411-7. 2010
    ..The aim of this study was to validate the model using French data...
  17. ncbi Plasma endothelin-1 and clinical manifestations of neonatal sepsis
    Jose Figueras-Aloy
    Neonatal Service, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Unitat Integrada de Pediatria, Hospital Clinic, 08028 Barcelona, Spain
    J Perinat Med 32:522-6. 2004
    ..To determine whether plasma endothelin-1 (ET-1) relates to clinical manifestations of sepsis in the newborn, especially with systemic hypotension, acidosis, severe hypoxemia (which may represent pulmonary hypertension) and oliguria...
  18. ncbi Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group
    Xavier Carbonell-Estrany
    Neonatology Service, Hospital Clinic, Institut Clinic Ginecologia Obstetricia i Neonatologia, C. Sabino Arana No 1, 08028 Barcelona, Spain
    Pediatr Infect Dis J 22:S55-7; discussion S57. 2003
    ....
  19. ncbi Treatment and prevention of malaria in pregnancy and newborn
    Oriol Coll
    Department of Maternal Fetal Medicine, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic de Barcelona, Barcelona, Spain
    J Perinat Med 36:15-29. 2008
    ..In this paper, we review the pathology, diagnosis, and current recommendations for treatment and prevention of malaria in the pregnant woman and her infant...
  20. ncbi Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia
    Francesc Botet
    Neonatology Service, Hospital Clinic de Barcelona, Sabino de Arana 1, 08028 Barcelona, Spain
    BMC Pediatr 12:63. 2012
    ..abstract:..
  21. ncbi [Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain]
    J Figueras-Aloy
    Servicio de Neonatologia, Hospital Clinic, Barcelona, Espana
    An Pediatr (Barc) 71:47-53. 2009
    ..The aim of the study was to evaluate the risk factor associations for respiratory syncytial virus (RSV) hospitalization in preterm infants from 32 to 35 weeks gestation, treated during two consecutive RSV seasons in Spain...
  22. ncbi Impact of chorioamnionitis on exhaled nitric oxide and endotracheal aspirate levels of nitrites-nitrates and interleukin-8 in mechanically ventilated preterm neonates
    Josep Figueras-Aloy
    Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Hospital Clinic, IDIBAPS Institut d Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain
    Pediatr Pulmonol 46:595-603. 2011
    ..To assess the influence of maternal chorioamnionitis on early exhaled nitric oxide (NO) and levels of nitrites-nitrates and interleukin (IL)-8 in endotracheal aspirate fluid in mechanically ventilated preterm neonates...
  23. ncbi The impact of clinical maternal chorioamnionitis on neurological and psychological sequelae in very-low-birth weight infants: a case-control study
    Francesc Botet
    Neonatology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain
    J Perinat Med 39:203-8. 2011
    ..To assess the relationship between clinically maternal chorioamnionitis and outcome in preterm very-low-birth weight (VLBW) infants...
  24. ncbi Guidelines on CMV congenital infection
    Oriol Coll
    Department of Maternal Fetal Medicine, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Hospital Clinic, University of Barcelona, Barcelona, Spain
    J Perinat Med 37:433-45. 2009
    ..In this paper, aspects of CMV infection in the pregnant woman and her infant are reviewed...
  25. ncbi Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis
    Jose Figueras-Aloy
    Servicio Neonatología, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Spain
    Am J Perinatol 24:331-8. 2007
    ..These levels were related to the clinical severity of the disease. Soluble VCAM-1 levels increased only slightly in HC + sepsis. Soluble L-selectin and sP-selectin did not change...
  26. ncbi Timing of umbilical cord clamping: new thoughts on an old discussion
    Gemma Arca
    Service of Neonatology, Hospital Clinic de Barcelona, Universitat de Barcelona, IDIBAPS, Barcelona, Spain
    J Matern Fetal Neonatal Med 23:1274-85. 2010
    ..However, further randomised clinical studies are needed to confirm the benefits of delayed cord clamping...
  27. ncbi Nonimmune hydrops fetalis due to congenital xerocytosis
    María Pilar Vicente-Gutiérrez
    Unitat Integrada de Pediatria Hospital Clínic Hospital Sant Joan de Déu, Barcelona, Spain
    J Perinatol 25:63-5. 2005
    ..We report a case of hydrops fetalis secondary to hereditary xerocytosis. Management with intrauterine erythrocyte and albumin transfusions resulted in a favorable postnatal course...
  28. ncbi The effects of varying protein and energy intakes on the growth and body composition of very low birth weight infants
    Juan Antonio Costa-Orvay
    Neonatal Unit, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
    Nutr J 10:140. 2011
    ..To determine the effects of high dietary protein and energy intake on the growth and body composition of very low birth weight (VLBW) infants...
  29. ncbi Guideline for the use of antenatal corticosteroids for fetal maturation
    Xavier Miracle
    Neonatology Service, Hospital Clinic, Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Universitat de Barcelona, Barcelona, Spain
    J Perinat Med 36:191-6. 2008
    ..Are antenatal corticosteroids indicated in women with premature rupture of membranes (PROM)? Is the use of ACS recommended in pregnancies complicated by maternal diabetes mellitus? Should the treatment with corticosteroids be repeated?..
  30. ncbi Differences in fat content and fatty acid proportions among colostrum, transitional, and mature milk from women delivering very preterm, preterm, and term infants
    Carolina Moltó-Puigmartí
    Department of Nutrition and Food Science, Faculty of Pharmacy, University of Barcelona Avda Joan XXIII s n CE 08028, Barcelona, Spain
    Clin Nutr 30:116-23. 2011
    ..We studied the changes in fat content and fatty acid proportions throughout lactation in very preterm, preterm, and full term milk, and the differences among gestational age groups...
  31. ncbi Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing
    Eric A F Simoes
    Department of Pediatric Infectious Diseases, University of Colorado School of Medicine and The Children s Hospital, Denver, CO 80218, USA
    J Pediatr 151:34-42, 42.e1. 2007
    ..We hypothesized that palivizumab, by ameliorating or preventing early RSV LRTI in preterm infants, might decrease later recurrent wheezing...
  32. ncbi Impact of severe disease caused by respiratory syncytial virus in children living in developed countries
    Eric A Simoes
    Section of Infectious Diseases, Department of Pediatrics, University of Colorado Health Sciences Center and The Children's Hospital, Denver, CO, USA
    Pediatr Infect Dis J 22:S13-8; discussion S18-20. 2003
    ..Findings from this comprehensive, prospective study served as the basis for the development of standards for the prevention of respiratory syncytial virus infection by the Spanish Society of Neonatology...